|
Cause for Delay
|
7
|
Resverlogix Corp.
|
Mar 16, 2017 10:45AM
|
|
Data Safety Monitoring Board Udpate
|
6
|
Resverlogix Corp.
|
Dec 05, 2016 12:21PM
|
|
Made for TV Movie
|
3
|
Resverlogix Corp.
|
Aug 28, 2017 08:02AM
|
|
New Pfizer Antiviral Drug
|
3
|
Resverlogix Corp.
|
Nov 05, 2021 07:01AM
|
|
Pfizer Paxlovid
|
3
|
Resverlogix Corp.
|
Dec 22, 2021 01:53PM
|
|
Re: 0.05 P-values -- A bridge too far ?
|
3
|
Resverlogix Corp.
|
Feb 12, 2020 12:11PM
|
|
Re: 10BagR's Violation
|
3
|
Resverlogix Corp.
|
Nov 27, 2020 03:16PM
|
|
Re: 10BagR's Violation message from Nov 27
|
4
|
Resverlogix Corp.
|
Dec 04, 2020 07:24AM
|
|
Re: 5 million shares
|
2
|
Resverlogix Corp.
|
Sep 27, 2019 09:54AM
|
|
Re: 5 million shares
|
2
|
Resverlogix Corp.
|
Sep 27, 2019 09:59AM
|
|
Re: 5 million shares
|
3
|
Resverlogix Corp.
|
Sep 27, 2019 10:29AM
|
|
Re: A few things
|
2
|
Resverlogix Corp.
|
Oct 17, 2017 11:22AM
|
|
Re: AGM & PP
|
3
|
Resverlogix Corp.
|
Nov 24, 2020 08:03AM
|
|
Re: AGM attendance
|
4
|
Resverlogix Corp.
|
May 24, 2022 08:37PM
|
|
Re: Another variation
|
9
|
Resverlogix Corp.
|
Mar 04, 2021 07:48AM
|
|
Re: Another variation
|
8
|
Resverlogix Corp.
|
Mar 04, 2021 09:40AM
|
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
8
|
Resverlogix Corp.
|
Mar 03, 2021 11:44AM
|
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
11
|
Resverlogix Corp.
|
Mar 18, 2021 10:33AM
|
|
Re: approx. 85,000 deferred share units awarded
|
11
|
Resverlogix Corp.
|
Nov 05, 2020 03:44PM
|
|
Re: BTD
|
13
|
Resverlogix Corp.
|
Apr 24, 2022 09:25AM
|
